These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29143165)

  • 21. Dynamic conformational switching in the chemokine ligand is essential for G-protein-coupled receptor activation.
    Joseph PR; Sawant KV; Isley A; Pedroza M; Garofalo RP; Richardson RM; Rajarathnam K
    Biochem J; 2013 Dec; 456(2):241-51. PubMed ID: 24032673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptides derived from CXCL8 based on in silico analysis inhibit CXCL8 interactions with its receptor CXCR1.
    Jiang SJ; Liou JW; Chang CC; Chung Y; Lin LF; Hsu HJ
    Sci Rep; 2015 Dec; 5():18638. PubMed ID: 26689258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine-Tuning of GPCR-Chemokine Interactions. Design and Identification of Chemokine Analogues as Receptor Agonists, Biased Agonists, and Antagonists.
    Navarro J
    Biochemistry; 2019 Mar; 58(10):1432-1439. PubMed ID: 30726064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformational plasticity and dynamic interactions of the N-terminal domain of the chemokine receptor CXCR1.
    Kharche S; Joshi M; Chattopadhyay A; Sengupta D
    PLoS Comput Biol; 2021 May; 17(5):e1008593. PubMed ID: 34014914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monomeric variants of IL-8: effects of side chain substitutions and solution conditions upon dimer formation.
    Lowman HB; Fairbrother WJ; Slagle PH; Kabakoff R; Liu J; Shire S; Hébert CA
    Protein Sci; 1997 Mar; 6(3):598-608. PubMed ID: 9070442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discrete steps in binding and signaling of interleukin-8 with its receptor.
    Wu L; Ruffing N; Shi X; Newman W; Soler D; Mackay CR; Qin S
    J Biol Chem; 1996 Dec; 271(49):31202-9. PubMed ID: 8940121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions.
    Joseph PR; Mosier PD; Desai UR; Rajarathnam K
    Biochem J; 2015 Nov; 472(1):121-33. PubMed ID: 26371375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of a CXC chemokine-receptor fragment in complex with interleukin-8.
    Skelton NJ; Quan C; Reilly D; Lowman H
    Structure; 1999 Feb; 7(2):157-68. PubMed ID: 10368283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear magnetic resonance solution structure of truncated human GRObeta [5-73] and its structural comparison with CXC chemokine family members GROalpha and IL-8.
    Qian YQ; Johanson KO; McDevitt P
    J Mol Biol; 1999 Dec; 294(5):1065-72. PubMed ID: 10600366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1H NMR solution structure of an active monomeric interleukin-8.
    Rajarathnam K; Clark-Lewis I; Sykes BD
    Biochemistry; 1995 Oct; 34(40):12983-90. PubMed ID: 7548056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-resolution NMR spectroscopy of a GPCR in aligned bicelles.
    Park SH; Prytulla S; De Angelis AA; Brown JM; Kiefer H; Opella SJ
    J Am Chem Soc; 2006 Jun; 128(23):7402-3. PubMed ID: 16756269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The CXCL8-CXCR1/2 pathways in cancer.
    Liu Q; Li A; Tian Y; Wu JD; Liu Y; Li T; Chen Y; Han X; Wu K
    Cytokine Growth Factor Rev; 2016 Oct; 31():61-71. PubMed ID: 27578214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane-induced organization and dynamics of the N-terminal domain of chemokine receptor CXCR1: insights from atomistic simulations.
    Kharche S; Joshi M; Sengupta D; Chattopadhyay A
    Chem Phys Lipids; 2018 Jan; 210():142-148. PubMed ID: 28939366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands.
    Moussouras NA; Getschman AE; Lackner ER; Veldkamp CT; Dwinell MB; Volkman BF
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28869519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of K11R and G31P Mutations on the Structure and Biological Activities of CXCL8: Solution Structure of Human CXCL8
    Cheng HT; Yu HY; Gordon JR; Li F; Cheng JW
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28754019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re-evaluation of chicken CXCR1 determines the true gene structure: CXCLi1 (K60) and CXCLi2 (CAF/interleukin-8) are ligands for this receptor.
    Poh TY; Pease J; Young JR; Bumstead N; Kaiser P
    J Biol Chem; 2008 Jun; 283(24):16408-15. PubMed ID: 18417470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping the binding surface of interleukin-8 complexed with an N-terminal fragment of the type 1 human interleukin-8 receptor.
    Clubb RT; Omichinski JG; Clore GM; Gronenborn AM
    FEBS Lett; 1994 Jan; 338(1):93-7. PubMed ID: 8307164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCR1 and CXCR2 activation and regulation. Role of aspartate 199 of the second extracellular loop of CXCR2 in CXCL8-mediated rapid receptor internalization.
    Nasser MW; Raghuwanshi SK; Malloy KM; Gangavarapu P; Shim JY; Rajarathnam K; Richardson RM
    J Biol Chem; 2007 Mar; 282(9):6906-15. PubMed ID: 17204468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCL1/MGSA Is a Novel Glycosaminoglycan (GAG)-binding Chemokine: STRUCTURAL EVIDENCE FOR TWO DISTINCT NON-OVERLAPPING BINDING DOMAINS.
    Sepuru KM; Rajarathnam K
    J Biol Chem; 2016 Feb; 291(8):4247-55. PubMed ID: 26721883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Requirement for Neutrophil Glycosaminoglycans in Chemokine:Receptor Interactions Is Revealed by the Streptococcal Protease SpyCEP.
    Goldblatt J; Lawrenson RA; Muir L; Dattani S; Hoffland A; Tsuchiya T; Kanegasaki S; Sriskandan S; Pease JE
    J Immunol; 2019 Jun; 202(11):3246-3255. PubMed ID: 31010851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.